WO2008093360A3 - A process for preparation of (s)-(+)-n-methyl-3(1-naphthyloxy)-3(2-thienyl)propylamine hydrochloride - Google Patents
A process for preparation of (s)-(+)-n-methyl-3(1-naphthyloxy)-3(2-thienyl)propylamine hydrochloride Download PDFInfo
- Publication number
- WO2008093360A3 WO2008093360A3 PCT/IN2008/000062 IN2008000062W WO2008093360A3 WO 2008093360 A3 WO2008093360 A3 WO 2008093360A3 IN 2008000062 W IN2008000062 W IN 2008000062W WO 2008093360 A3 WO2008093360 A3 WO 2008093360A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- preparation
- naphthyloxy
- thienyl
- methyl
- propylamine hydrochloride
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention provides an improved process for preparation of intermediate of Duloxetine base and hydrochloride salt thereof.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN168/MUM/2007 | 2007-01-31 | ||
IN168MU2007 | 2007-01-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2008093360A2 WO2008093360A2 (en) | 2008-08-07 |
WO2008093360A3 true WO2008093360A3 (en) | 2008-10-02 |
Family
ID=39535547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2008/000062 WO2008093360A2 (en) | 2007-01-31 | 2008-01-31 | A process for preparation of (s)-(+)-n-methyl-3(1-naphthyloxy)-3(2-thienyl)propylamine hydrochloride |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008093360A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009150238A2 (en) * | 2008-06-13 | 2009-12-17 | Krka, D.D. Novo Mesto | Gastro-resistant pharmaceutical oral compositions comprising duloxetine or its pharmaceutically acceptable derivatives |
WO2010079404A2 (en) * | 2009-01-06 | 2010-07-15 | Alembic Limited | An improved process for the preparation of duloxetine and salts thereof |
WO2011033366A2 (en) * | 2009-09-16 | 2011-03-24 | Jubilant Life Sciences Limited | Process for the preparation of duloxetine hydrochloride and its precursors |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5362886A (en) * | 1993-10-12 | 1994-11-08 | Eli Lilly And Company | Asymmetric synthesis |
WO2006045255A1 (en) * | 2004-10-26 | 2006-05-04 | Zentiva, A.S. | Method of manufacturing (s)-n-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine hydrochloride (duloxetine) |
US20060194869A1 (en) * | 2004-12-23 | 2006-08-31 | Santiago Ini | Process for preparing pharmaceutically acceptable salts of duloxetine and intermediates thereof |
-
2008
- 2008-01-31 WO PCT/IN2008/000062 patent/WO2008093360A2/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5362886A (en) * | 1993-10-12 | 1994-11-08 | Eli Lilly And Company | Asymmetric synthesis |
WO2006045255A1 (en) * | 2004-10-26 | 2006-05-04 | Zentiva, A.S. | Method of manufacturing (s)-n-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine hydrochloride (duloxetine) |
US20060194869A1 (en) * | 2004-12-23 | 2006-08-31 | Santiago Ini | Process for preparing pharmaceutically acceptable salts of duloxetine and intermediates thereof |
Non-Patent Citations (1)
Title |
---|
F. A. COTTON AND G. WILKINSON: "Advanced Inorganic Chemistry, 3rd Edition", 1972, JOHN WILEY INTERSCIENCE, NEW YORK, US, XP002486191 * |
Also Published As
Publication number | Publication date |
---|---|
WO2008093360A2 (en) | 2008-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1199253A1 (en) | Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof toblock reuptake of norepinephrine, dopamine, and serotonin | |
IL184185A0 (en) | Pure duloxetine hydrochloride | |
IL216247A0 (en) | Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine and serotonin | |
EP1746985A4 (en) | Method for augmenting the effects of serotonin reuptake inhibitors | |
IL183245A0 (en) | Process for preparing phamaceutically acceptable salts of duloxetine and intermediates thereof | |
WO2007119114A3 (en) | Improved synthesis and preparations of duloxetine salts | |
EP1976844A4 (en) | Improved process for pure duloxetine hydrochloride | |
ZA200609205B (en) | Crystalline forms of duloxetine free base | |
GB0518612D0 (en) | A method of forming conductive tracks | |
AP2005003467A0 (en) | N-pyrrolidin-3-YL-amide derivatives as serotonin and noradrenaline reuptake inhibitors. | |
EP1819337A4 (en) | Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin | |
ZA200702333B (en) | Cyclic amine derivative or salt thereof | |
WO2006081515A3 (en) | Duloxetine hydrochloride polymorphs | |
IL191921A0 (en) | A novel process for the preparation of (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, a duloxetine intermediate | |
DE502005000466D1 (en) | Lever-like cam follower | |
GB0612508D0 (en) | Crystalline duloxetine hydrochloride | |
WO2008093360A3 (en) | A process for preparation of (s)-(+)-n-methyl-3(1-naphthyloxy)-3(2-thienyl)propylamine hydrochloride | |
GB0612506D0 (en) | Crystalline duloxetine hydrochloride | |
WO2010117979A3 (en) | Serotonin and norepinephrine reuptake inhibitor | |
WO2007134168A3 (en) | Process for preparing duloxetine | |
ZA201201570B (en) | A method of crystallization of (s)-n-methyl-3-1(1-naphthyloxy)-3-(2-thienyl)propylamine hydrochloride (duloxetine) | |
SI1937662T1 (en) | Process for the preparation of duloxetine | |
IL184187A0 (en) | Crystal forms of (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine oxalate and the preparation thereof | |
WO2007067581A8 (en) | 2-(n-methyl-propanamine)-3-(2-naphthol) thiophene, an impurity of duloxetine hydrochloride | |
WO2007038253A3 (en) | Dnt-maleate and methods of preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08720123 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08720123 Country of ref document: EP Kind code of ref document: A2 |